EASL – International Liver Congress 2022

22-26 June, 2022
London, UK.

ENYO Pharma will attend the EASL International Liver Congress at London in April 2022.

https://easl.eu/event/international-liver-congress-2022/

Read more »

Published on 12/11/2021

International Workshop on HBV Cure 2021 (Sponsorship)

Virtual Event
9-10 November 2021

ENYO Pharma sponsors and attends the International Workshop on HBV Cure 2021 organized by Virology Education in close collaboration with the Toronto Centre for Liver Disease and chaired by Drs. Harry Janssen and Adam Gehring, the International Workshop on HBV Cure.
https://academicmedicaleducation.com/hbv-cure-2021/

Read more »

Published on 10/11/2021

ENYO Pharma Announces Two Vonafexor Data Presentations at AASLD The Liver Meeting

Lyon, France. November 3rd, 2021 – ENYO Pharma (ENYO), a private clinical stage biotechnology company developing innovative drug candidates, today announced that two abstracts on Vonafexor were accepted one as oral presentation and one as poster during the upcoming The Liver Meeting® 2021, organized by the American Association for the Study of Liver Diseases (AASLD) on November 12-15, 2021.

Read more »

Published on 03/11/2021

Etienne Morel’s talk at ITMO Cell Biology (Aviesan)

Etienne Morel, collaborator of ENYO Pharma, gave a talk describing the results of our collaboration entitled: “Mitochondrial morphodynamics and ER-mitochondria membrane crosstalk in antiviral innate immunity” at “ITMO Cell biology, development and evolution” event organized by Aviesan on October the 6th, 2021.

Conference description

Read more »

Published on 07/10/2021

UBS Biotech Private Company Event

Virtual Event
September 22-23, 2021

Jacky Vonderscher, our CEO, gave a talk during the plenary of the UBS Biotech Private Company Event.

Read more »

Published on 01/10/2021